secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001640334-24-001915
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences announces annual meeting results; re-elects directors and ratifies auditor
--------------------------------------------------------------------------------

- 40.9% of shares represented at Dec 20, 2024 annual meeting (1,319,986 of 3,227,700 outstanding).
- Directors Steven Kelly and R. Martin Emanuele re-elected to Class I board seats until 2027.
- Ratification of Malone Bailey LLP as independent auditor for FY ending Dec 31, 2024 (1,258,378 for, 57,083 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033424001915/0001640334-24-001915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033424001915/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-24-001915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer